Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Adverse events following immunization: perception and evidence.

Bonhoeffer J, Heininger U.

Curr Opin Infect Dis. 2007 Jun;20(3):237-46. Review.

PMID:
17471032
2.

Vaccine safety: current systems and recent findings.

Wharton M.

Curr Opin Pediatr. 2010 Feb;22(1):88-93. doi: 10.1097/MOP.0b013e3283350425. Review.

PMID:
19952750
3.

Ensuring vaccine safety in immunization programmes--a WHO perspective.

Jodar L, Duclos P, Milstien JB, Griffiths E, Aguado MT, Clements CJ.

Vaccine. 2001 Feb 8;19(13-14):1594-605.

PMID:
11166881
4.

Safety monitoring in vaccine development and immunization.

Lee CJ, Lee LH, Lu CH, Huang YJ, Chu ML.

Acta Paediatr Taiwan. 2006 Jan-Feb;47(1):7-13. Review. Erratum in: Acta Paediatr Taiwan. 2006 Mar-Apr;47(2):100.

PMID:
17016963
5.

Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.

Fernandes GC, Camacho LA, Sá Carvalho M, Batista M, de Almeida SM.

Vaccine. 2007 Apr 20;25(16):3124-8. Epub 2007 Jan 30.

PMID:
17316927
6.

A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004.

Chapman LE, Iskander JK, Chen RT, Neff J, Birkhead GS, Poland G, Gray GC, Siegel J, Sepkowitz K, Robertson RM, Yancy C, Guerra FA, Gardner P, Modlin JF, Maurer T, Berger T, Flanders WD, Shope R.

Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S271-93. doi: 10.1086/524750.

PMID:
18284368
7.

[Adverse events after vaccination].

Nøkleby H, Bergsaker MA.

Tidsskr Nor Laegeforen. 2006 Oct 5;126(19):2541-4. Review. Norwegian.

8.

[Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].

Yaméogo TM, Breugelmans JG, Kambou JL, Badolo O, Tiendrebéogo S, Traoré E, Avokey F, Yactayo S.

Med Trop (Mars). 2009 Aug;69(4):320-1. French.

PMID:
19725376
9.

Monitoring of adverse events during the 2003 mass vaccination campaign with a trivalent meningococcal A/C/W135 polysaccharide vaccine in Burkina Faso.

Bentsi-Enchill AD, Zongo I, Khamassi S, Pless R, Thombiano R, Tiéndrebéogo S, Nelson CB, Duclos P.

Vaccine. 2007 Sep 3;25 Suppl 1:A72-8. Epub 2007 May 7.

PMID:
17544552
10.

Risk perception, risk management and safety assessment: what can governments do to increase public confidence in their vaccine system?

MacDonald NE, Smith J, Appleton M.

Biologicals. 2012 Sep;40(5):384-8. doi: 10.1016/j.biologicals.2011.08.001. Epub 2011 Oct 10.

PMID:
21993306
11.
12.

The development of standardized case definitions and guidelines for adverse events following immunization.

Kohl KS, Gidudu J, Bonhoeffer J, Braun MM, Buettcher M, Chen RT, Drammeh B, Duclos P, Heijbel H, Heininger U, Hummelman E, Jefferson T, Keller-Stanislawski B, Loupi E, Marcy SM.

Vaccine. 2007 Aug 1;25(31):5671-4. Epub 2007 Mar 12. No abstract available.

PMID:
17400339
13.

A view from the media on vaccine safety.

Brown P.

Bull World Health Organ. 2000;78(2):216-8.

14.

Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board.

Neff J, Modlin J, Birkhead GS, Poland G, Robertson RM, Sepkowitz K, Yancy C, Gardner P, Gray GC, Maurer T, Siegel J, Guerra FA, Berger T, Flanders WD, Shope R; Advisory Committee on Immunization Practices; Armed Forces Epidemiological Board.

Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S258-70. doi: 10.1086/524749.

PMID:
18284367
15.

Rotavirus vaccines in developed countries.

Buttery JP, Kirkwood C.

Curr Opin Infect Dis. 2007 Jun;20(3):253-8. Review.

PMID:
17471034
16.
17.

Field evaluation of vaccine safety.

Tozzi AE.

Vaccine. 2004 May 7;22(15-16):2091-5. Review.

PMID:
15121330
18.

Biologically plausible and evidence-based risk intervals in immunization safety research.

Rowhani-Rahbar A, Klein NP, Dekker CL, Edwards KM, Marchant CD, Vellozzi C, Fireman B, Sejvar JJ, Halsey NA, Baxter R; Risk Interval Working Group of the Clinical Immunization Safety Assessment Network.

Vaccine. 2012 Dec 17;31(1):271-7. doi: 10.1016/j.vaccine.2012.07.024. Epub 2012 Jul 24. Review.

PMID:
22835735
19.

Allergic reactions to vaccines.

Alves RR, Gaspar A, Ferreira MB.

Eur Ann Allergy Clin Immunol. 2007 Oct;39(8):269-77. Review.

PMID:
18237005
20.

Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.

Niu MT, Ball R, Woo EJ, Burwen DR, Knippen M, Braun MM; VAERS Working Group.

Vaccine. 2009 Jan 7;27(2):290-7. doi: 10.1016/j.vaccine.2008.10.044. Epub 2008 Nov 6.

PMID:
18992783

Supplemental Content

Support Center